An interventional study of CPAP and Control in Obstructive Sleep Apnea and Refractory Arterial Hypertension, sponsored by Corporacion Parc Tauli. Completed at 1 site in Spain. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2017-02-09.
Sponsored by Corporacion Parc Tauli · Not applicable, Interventional, and Treatment
The purpose of this study is to determine the effects of CPAP treatment on blood pressure in patients with sleep apnea syndrome (SAS) and refractory arterial hypertension (RAH).
Also, some of the mechanisms mediating SAS and RAH (systemic inflammation, oxidative stress, sympathetic hyperactivity) will be analyzed.
1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.
This study's enrollment of 68 is above the median of 50 across 965 interventional studies indexed under Apnea.
Browse Apnea studies →Corporacion Parc Tauli is the lead sponsor of 163 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
nocturnal continuous positive airways pressure
Device: CPAP
Waiting list,3 months without any change in their treatment, come into the CPAP procedure after that time
Device: Control
continuous positive airways pressure
Patients are 3 months without any change in their treatment, and are in the waiting list to come into the CPAP procedure after that time
24 hours blood pressure monitoring
Time frame: basal and after three months of CPAP treatment
oxidative stress and inflammatory mediators
Time frame: basal and after three months of CPAP treatment
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Corporacion Parc Tauli